ApoE Promotes the Proteolytic Degradation of Aβ

Autor: Noam Zelcer, Timothy M. Willson, C. Y. Daniel Lee, Jill C. Richardson, Shweta Mandrekar, David M. Holtzman, Jon L. Collins, Jonathan D. Smith, Qingguang Jiang, Gary E. Landreth, David Riddell, Paige E. Cramer, Karen Mann, Peter Tontonoz, Brandy L. Wilkinson, Bruce T. Lamb, Thomas A. Comery
Přispěvatelé: Other departments
Rok vydání: 2008
Předmět:
Apolipoprotein E
Aging
Benzylamines
Time Factors
HUMDISEASE
Receptors
Cytoplasmic and Nuclear

Plaque
Amyloid

Benzoates
Mice
0302 clinical medicine
Receptor
Neprilysin
Cells
Cultured

Liver X Receptors
0303 health sciences
Microglia
Behavior
Animal

General Neuroscience
Brain
Orphan Nuclear Receptors
Cell biology
DNA-Binding Proteins
medicine.anatomical_structure
Biochemistry
lipids (amino acids
peptides
and proteins)

Alzheimer's disease
ATP Binding Cassette Transporter 1
Agonist
medicine.drug_class
Neuroscience(all)
Enzyme-Linked Immunosorbent Assay
Mice
Transgenic

Biology
MOLNEURO
Article
03 medical and health sciences
Apolipoproteins E
Alzheimer Disease
Memory
mental disorders
medicine
Animals
Liver X receptor
030304 developmental biology
Amyloid beta-Peptides
Dose-Response Relationship
Drug

medicine.disease
Peptide Fragments
nervous system diseases
Mice
Inbred C57BL

Disease Models
Animal

Animals
Newborn

CELLBIO
ATP-Binding Cassette Transporters
030217 neurology & neurosurgery
Homeostasis
Zdroj: Neuron, 58(5), 681-693. Cell Press
ISSN: 0896-6273
DOI: 10.1016/j.neuron.2008.04.010
Popis: Apolipoprotein E is associated with age-related risk for Alzheimer’s disease and plays critical roles in Aβ homeostasis. We report that ApoE plays a previously unappreciated role in facilitating the proteolytic clearance of soluble Aβ from the brain. The endolytic degradation of Aβ peptides within microglia by neprilysin and related enzymes is dramatically enhanced by ApoE. Similarly, Aβ degradation extracellularly by insulin degrading enzyme is facilitated by ApoE. The capacity of ApoE to promote Aβ degradation is dependent upon the ApoE isoform and its lipidation status. The enhanced expression of lipidated ApoE, through the activation of liver X receptors, stimulates Aβ degradation. Indeed, aged Tg2576 mice treated with the LXR agonist GW3965 exhibited a dramatic reduction in brain Aβ load. GW3965 treatment also reversed contextual memory deficits. These data demonstrate a novel mechanism through which ApoE facilitates the clearance of Aβ from the brain and suggest that LXR agonists may represent a novel therapy for AD.
Databáze: OpenAIRE